• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,921.07 594.83
(1.14%)
Dow Jones
7,504.24 0.01
(0.00%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
95.28 0.28
(0.30%)
EUR-INR
108.75 0.54
(0.50%)
GBP-INR
126.99 1.06
(0.84%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
138.7336605
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
102.97
11902.13
EPS(TTM)
Face Value()
Div & Yield %
5.91
1
0.1
 

J&K Bank gains as gross advances grow 17% YoY in Q4 FY26
Apr 06,2026
Total business stood at Rs 290,340.57 crore as of 31 March 2026, up 13.61%, compared with Rs 255,554.95 crore as of 31 March 2025.

Total deposits increased 11.30% to Rs 165,354.04 crore as of 31 March 2026, compared with Rs 148,569.46 crore as of 31 March 2025. CASA deposits rose 8.07% YoY to Rs 75,478.40 crore as of 31 March 2026.

Gross investment declined 1.55% to Rs 41,319.50 crore as of 31 March 2026, compared with Rs 41,970.20 crore as of 31 March 2025.

J&K Bank offers banking services under the three major divisions as support services, depository services, and third-party services.

The bank reported a 10.4% jump in net profit to Rs 586.73 crore on a 4.2% rise in total income to Rs 3,592.90 crore in Q3 FY26 over Q3 FY25.